Medicinal Cannabis Industry Australia (MCIA) Say TGA Need To Double CBD Dosage To Ensure Efficacy Of Products Sold

Cannabiz (Aus) report this morning..

However, it said it would continue to work with the TGA with a view to lifting the dose to 300 mg/day as “this is the threshold at which higher quality evidence accumulates around CBD efficacy, in the absence of significant safety concerns”.

MCIA chair Peter Crock added: “Down-scheduling CBD will benefit patients by allowing them to move from the illicit market and providing easier and more affordable access to high-quality products.”

While noting products will require TGA approval and inclusion on the Australian Register of Therapeutic Goods (ARTG), along with a number of other restrictions, Crock said the decision will provide a pathway for the industry to develop products for this market.

Read the full Cannabiz story and all the other industry reactions at

Industry reacts to TGA down-scheduling decision with cautious optimism

 

Hemp Industry Daily have also picked up on the Cannabiz story at

Australia nixes prescription requirement for select CBD products

 

Primary Sponsor

Top Marijuana Blog